Cargando…
Elevated plasma α1-antichymotrypsin is a biomarker candidate for malaria patients
Advancements in the field of proteomics have provided opportunities to develop diagnostic and therapeutic strategies against various diseases. About half of the world’s population remains at risk of malaria. Caused by protozoan parasites of the genus Plasmodium, malaria is one of the oldest and larg...
Autores principales: | Bahk, Young Yil, Lee, Sang Bong, Kim, Jong Bo, Kim, Tong-Soo, Hong, Sung-Jong, Kim, Dong Min, Lee, Sungkeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712706/ https://www.ncbi.nlm.nih.gov/pubmed/36195566 http://dx.doi.org/10.5483/BMBRep.2022.55.11.126 |
Ejemplares similares
-
Urinary α(1)-Antichymotrypsin: A Biomarker of Prion Infection
por: Miele, Gino, et al.
Publicado: (2008) -
Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value
por: Lok, S. I., et al.
Publicado: (2014) -
Genetic Diversity of Plasmodium vivax Causing Epidemic Malaria in the Republic of Korea
por: Bahk, Young Yil, et al.
Publicado: (2018) -
Awareness and Opinions of Inhabitants on Vivax Malaria in Two Endemic Areas, Gyeonggi-do, Korea
por: Bahk, Young Yil, et al.
Publicado: (2021) -
Expression of alpha-1-antichymotrypsin in prostate carcinoma.
por: Cho, N. H., et al.
Publicado: (1997)